Weight Loss

CBD Does Not Go Better with Coke

Coca-Cola is eyeing CBD as a functional food additive, while the beverage giant promotes sugary drinks for overweight children.

CB1, Gene Expression & Obesity

Abstract DNA strand

A synthetic cannabinoid pharmaceutical called Rimonabant was briefly approved in Europe as an anti-obesity drug. Rimonabant inhibits the CB1 receptor, reducing its activity below normal levels and blocking other compounds, like THC or anandamide, from activating it. It was taken off the market in 2008 for causing suicidal thoughts, among other psychiatric problems, which occurred when this pharmaceutical shut down cannabinoid activity in parts of the brain.

Obesity

Obesity is a condition that is associated with an excess amount of body fat, in particular a Body Mass Index (BMI) of 30 or greater. Often there are genetic and environmental at play. Obesity is associated with chronic inflammation, diabetes, and many other metabolic conditions.

Diabetes

Diabetes is a condition in which your body does not properly process sugar. It can cause nerve damage, eye problems, heart disease or stroke. Symptoms include fatigue, blurred vision, feelings of thirst, slow healing of cuts or bruises, and tingling, pain or numbness in hands and feet (neuropathy).

Top Stories